Combined Treatment of Colon Adenocarcinoma in Rats with Tumor Necrosis Factor and the Interferon Inducer ABPP

Richard L. Marquet, Alexander M.m. Eggermont, Ron W.F. de Bruin, Walter Fiers, Johannes Jeekel

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

It is well documented that the antitumor capacity of tumor necrosis factor (TNF) can be enhanced by interferons (IFNs), notably IFN-γ. The aim of this study was to investigate the efficacy of a combined treatment with TNF and the IFN-inducer 2-amino-5-bromo-6-phenyl-4-pyrimidinone (ABPP) on a transplantable colon carcinoma (CC531) in rats. The tumor was implanted under the kidney capsule of syngeneic rats; the tumors were removed a week after implantation and growth was assessed by weighing. The animals were treated with 1 μg of TNF, given i.v. on days 0, 2, and 4; and with 250 mg/kg of ABPP, administered i.p. on days 0 and 1. The results of two separate experiments indicated that both TNF and ABPP had a significant inhibitory effect on tumor growth. Combined, the two agents were found to act additively. In the dosage used, TNF toxicity was mild, transient, and not influenced by ABPP.

Original languageEnglish
Pages (from-to)319-323
Number of pages5
JournalJournal of Interferon Research
Volume8
Issue number3
DOIs
Publication statusPublished - Jun 1988
Externally publishedYes

Fingerprint

Dive into the research topics of 'Combined Treatment of Colon Adenocarcinoma in Rats with Tumor Necrosis Factor and the Interferon Inducer ABPP'. Together they form a unique fingerprint.

Cite this